Usability Testing In FDA’s Crosshairs As Manufacturers Seek Human Factors Buy-In
This article was originally published in The Silver Sheet
Executive Summary
Device manufacturers that fail to conduct formative testing early on in human factors efforts run the risk of making devices that don’t interact well with users and ultimately require costly fixes. Formatives are “often essential for achieving acceptable human factors validation testing results, minimizing FDA [pre-market] review time and agency requests for additional information,” says CDRH usability guru Ron Kaye. Meanwhile, a quality assurance official at device-maker Kinetic Concepts describes how his firm uses simulation rooms, and other experts offer advice on engraining human factors concepts into company culture.
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.